Strides Pharma Science Ltd. | Mid-cap | Healthcare
₹829.90
0.37%
| Strides Pharma Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 38.9B
Gross Profit 21.7B 55.66%
Operating Income 4.8B 12.39%
Net Income -943.1M -2.42%
EPS (Diluted) -₹7.76

Balance Sheet Metrics

Total Assets 58.4B
Total Liabilities 37.7B
Shareholders Equity 20.7B
Debt to Equity 1.82

Cash Flow Metrics

Operating Cash Flow 36.0B
Free Cash Flow 4.4B

Revenue & Profitability Trend

Strides Pharma Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 38.9B 36.1B 30.2B 32.5B 26.6B
Cost of Goods Sold 17.3B 17.0B 15.8B 14.1B 11.8B
Gross Profit 21.7B 19.1B 14.4B 18.4B 14.7B
Operating Expenses 8.3B 8.6B 8.4B 7.2B 5.8B
Operating Income 4.8B 1.4B -2.4B 4.2B 3.7B
Pre-tax Income -1.2B -2.9B -6.5B 2.8B 546.8M
Income Tax 315.9M -553.0M -1.8B 316.5M 113.2M
Net Income -943.1M -2.1B -4.7B 2.6B 306.0M
EPS (Diluted) -₹7.76 -₹22.49 -₹51.28 ₹29.92 ₹4.06

Income Statement Trend

Strides Pharma Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 29.7B 32.5B 33.6B 28.2B 23.7B
Non-Current Assets 28.7B 33.9B 36.1B 42.0B 37.8B
Total Assets 58.4B 66.4B 69.8B 70.2B 61.5B
Liabilities
Current Liabilities 28.8B 29.9B 34.1B 27.4B 25.4B
Non-Current Liabilities 8.9B 14.8B 11.8B 14.6B 10.1B
Total Liabilities 37.7B 44.7B 45.9B 42.0B 35.6B
Equity
Total Shareholders Equity 20.7B 21.7B 23.8B 28.1B 25.9B

Balance Sheet Composition

Strides Pharma Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 36.8B -627.2M -2.7B -6.5B 2.9B
Operating Cash Flow 36.0B 2.9B -4.9B -5.7B -563.6M
Investing Activities
Capital Expenditures 681.0M 888.1M 72.6M 753.7M 39.6M
Investing Cash Flow 955.0M 68.0M 3.9B 179.1M -2.3B
Financing Activities
Dividends Paid -229.9M -135.2M - -224.3M -179.2M
Financing Cash Flow -3.7B -3.5B 634.0M 6.2B 1.6B
Free Cash Flow 4.4B 5.8B -505.3M -4.0B 1.8B

Cash Flow Trend

Strides Pharma Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 23.64
Forward P/E 13.71
Price to Book 3.19
Price to Sales 1.78
PEG Ratio 13.71

Profitability Ratios

Profit Margin 78.71%
Operating Margin 14.20%
Return on Equity 17.58%
Return on Assets 6.42%

Financial Health

Current Ratio 1.20
Debt to Equity 72.67
Beta 0.55

Per Share Data

EPS (TTM) ₹37.33
Book Value per Share ₹276.93
Revenue per Share ₹496.18

Financial data is updated regularly. All figures are in the company's reporting currency.